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Model membrane leakageThe cecropin-melittin hybrid antimicrobial peptide BP100 (H-KKLFKKILKYL-NH2) is selective for Gram-negative
bacteria, negatively chargedmembranes, andweakly hemolytic.We studied BP100 conformational and function-
al properties upon interaction with large unilamellar vesicles, LUVs, and giant unilamellar vesicles, GUVs,
containing variable proportions of phosphatidylcholine (PC) and negatively charged phosphatidylglycerol
(PG). CD andNMR spectra showed that upon binding to PG-containing LUVs BP100 acquiresα-helical conforma-
tion, the helix spanning residues 3–11. Theoretical analyses indicated that the helix is amphipathic and surface-
seeking. CD and dynamic light scattering data evinced peptide and/or vesicle aggregation,modulated by peptide:
lipid ratio and PG content. BP100 decreased the absolute value of the zeta potential (ζ) of LUVs with low PG
contents; for higher PG, binding was analyzed as an ion-exchange process. At high salt, BP100-induced LUVS
leakage requires higher peptide concentration, indicating that both electrostatic and hydrophobic interactions
contribute to peptide binding. While a gradual release took place at low peptide:lipid ratios, instantaneous loss
occurred at high ratios, suggesting vesicle disruption. Optical microscopy of GUVs conﬁrmed BP100-promoted
disruption of negatively charged membranes. The mechanism of action of BP100 is determined by both
peptide:lipid ratio andnegatively charged lipid content.While gradual release results frommembraneperturbation
by a small number of peptide molecules giving rise to changes in acyl chain packing, lipid clustering (leading to
membrane defects), and/or membrane thinning, membrane disruption results from a sequence of events –
large-scale peptide and lipid clustering, giving rise to peptide-lipid patches that eventually would leave the
membrane in a carpet-like mechanism.
© 2014 Elsevier B.V. All rights reserved.1. Introduction
Antimicrobial resistance to antibiotics is currently a serious global
heath issue. The alarming growth of microorganisms resistance to
conventional antibiotics and the stagnation in the development of
antibiotics with new mechanisms of action led to publication by the
World Health Organization (WHO) of a book pointing at strategies to
prevent this growth and emphasizing the urgent need for the develop-
ment of antibiotics with new mechanisms of action [1]. The use of
antimicrobial peptides (AMPs) has been considered as a possible solu-
tion. AMPs display a wide spectrum of action against Gram-positiveccov@iq.usp.br (I.M. Cuccovia).and Gram-negative bacteria, fungi, protozoa, virus, and mammalian
cells [2–7]. In addition, they usually act in the timescale of minutes
over multiple macromolecular targets, e.g. membranes, nucleic acids,
mitochondria, proteins, rendering it difﬁcult for microorganisms to
develop resistance [5,8–10].
Several mechanisms have been proposed for the action of AMPs at
the membrane level. Among those, the most frequently discussed are
the barrel-stave [11–13], the toroidal pore [14], and the carpet model
[15–17]. More recently, a model involving lipid clustering has also
been proposed [18–20]. For a detailed description of the existing
models, see ref. [7].
Among the AMPs, two peptides have been extensively studied,
cecropin A and melittin. Merriﬁeld and coworkers focus on obtaining
shorter hybrid peptides of these AMPs aiming at increasing their
effectivess and decreasing the damaging effects on host membranes
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antimicrobial concentrations) [21,22, for a review see ref. 23]. Another
approach proposes the use of synthetic combinatorial libraries to
engineer AMPs of high TI [24]. In this context, Badosa and collaborators
[25] identiﬁed the cationic eleven-residue hybrid peptide BP100
(H-KKLFKKILKYL-NH2), whose residues 2–7 correspond to residues
3–8 of cecropin A and whose residues 8–11 correspond to residues
6–9 of melittin, V8 being replaced by Y. In vitro, BP100 is highly active
and selective toward Gram-negative bacteria, including the phytopath-
ogenic bacterium E. amylovora. The peptide minimal inhibitory concen-
tration (MIC) for several Gram-negative bacteria is between 2.5 and
5 μM [25–27]). Furthermore, the peptide exhibits low cytotoxicity
against erythrocytes and ﬁbroblasts, and little susceptibility to protease
degradation [26,28].
Although the action of BP100 involves interaction with the mem-
brane, the mechanism is not completely understood at a molecular
level. Atomic force microscopy shows that at the MIC, BP100 progres-
sively destroys the E. coli cell envelope, leading to leakage of cytoplasmic
contents [26,27]. Under conditions where E. coli cells are exposed
to BP100 for long periods (≥2 h) and high peptide concentrations
(≥MIC), vesicle-like structures are formed and alterations occur in the
surface roughness. Zeta potential measurements of E. coli incubated
with increasing BP100 concentrations show a correlation between
the MIC (3 μM) and membrane surface charge neutralization [26].
In addition, BP100 labeled with ﬂuorescein-isothiocyanate translocates
into the cytosol of walled plant cells [28]. Furthermore, designed
constructs of BP100 fused to other peptides can transport cargoes into
plant cells [29,30].
Fluorescence and surface plasmon resonance (SPR) studies of model
membranes show that electrostatic interactions are important for
BP100 binding, as evidenced by its strong selectivity towards negatively
charged as compared to zwitterionicmembranes [27,28]. Moreover, the
peptide was also found to bind to and neutralize lipopolysaccharide
(LPS) and lipoteichoic acids (LTA), the negatively-charged molecules
in the cell envelope of Gram-negative and Gram-positive bacteria,
respectively [27]. For negatively charged membranes, at high peptide:
lipid ratios,membrane saturationwas observed and the effect correlates
with BP100-induced vesicle permeabilization, membrane electroneu-
trality, and vesicle aggregation. In addition, ﬂuorescence studies show
that BP100 translocates across lipid bilayers at both high and low
peptide:lipid ratios [28]. Brownian dynamics (BD) simulations of a
coarse-grained model of BP100 conﬁned within phospholipid bilayers
point to the acquisition of α-helical conformation by the peptide [31].
In agreement with the calculations, circular dichroism (CD) spectra of
the peptide show acquisition of α-helical conformation upon binding
to model membranes containing negatively charged phospholipids,
although the α-helical content was not calculated [27,32,33]. In a
study that came out early this year, Wadhwani and coworkers exam-
ined the conformation, membrane alignment, and dynamical behavior
of BP100 in DMPC:DPMG bilayers making use of oriented circular
dichroism (OCD) and solid-state 15 N NMR. The data indicated that the
BP100 helix is oriented roughly parallel to the membrane surface and
that the peptide is rotating fast around the bilayer normal [34].
Here we present a comprehensive study of the interaction between
BP100 andmodelmembranes (LUVs andGUVs) of variable lipid compo-
sition. We examined conformational aspects by performing theoretical
prediction of BP100 conformation and calculating the peptide
hydrophobicity and hydrophobic moment; experimental approaches
employed CD and NMR spectroscopies. Dynamic light scattering was
used to investigate the peptide effect on vesicle size and determination
of ζ from electrophoretic mobilities, provided information about its
effect upon membrane electrical properties. BP100-promoted leakage of
ﬂuorescent probes from the aqueous inner compartment of LUVs was
studied at low and high ionic strength. Finally, the peptide-membrane
interaction was also investigated by optical microscopy of GUVs.
The results provided evidence for a dependence of the mechanism ofaction of BP100 on peptide:lipid molar ratio and on the membrane
content of negatively charged phospholipid.
2. Materials and methods
2.1. Materials
1-Palmitoyl-2-oleoyl-sn-glycero-3-phosphocholine, (POPC),
L-α-phosphatidylglycerol (egg, sodium salt) (PG) and 1-palmitoyl-2-
oleoyl-sn-glycero-3-[phospho-rac-(1´-glycerol)] sodium salt (POPG),
were from Avanti Polar Lipids (Alabaster, AL). Egg phosphatidylcholine
(PC) was extracted from egg yolk and puriﬁed as previously described
[35]. Sephadex G-25 medium, Sephadex LH-20, sucrose, glucose,
tris-hydroxymethylaminomethane (Tris), methyl viologen (MV),
1,3,6,8-pyrenetetrasulfonic acid tetrasodium salt (PTS), polidocanol
(polyoxyethylene (9) lauryl ether), 2,2,2-triﬂuoroethanol (TFE),
4-methylpiperidine (4-MP), triisopropylsilane (TIPS), diisopropylcarb-
odiimide (DIC), 1-hydroxybenzotriazole (HOBt), trimethylsilyl propio-
nate (TSP), and α-cyano-4-hydroxycinnamic acid were from Sigma-
Aldrich (St Louis, MO). 2-Propanol, methanol and triﬂuoracetic acid
(TFA) were from VETEC (Rio de Janeiro, Brazil). Dichloromethane
(DCM) and acetonitrile (ACN) were from J.T. Baker (Xalostoc, Mexico).
2-cyano-2-(hydroxyimino) ethyl acetate (Oxyma) was from Merck
(Darmstadt, Germany). The amino acid derivatives (Fmoc-amino acids)
and the resin utilized for peptide synthesis were from Peptides
International (Louisville, KY). N,N-dimethylformamide (DMF) was
from SYNTH (São Paulo, Brazil) andwas dried under KOH and freshly
distilled before use. 5(6)-carboxyﬂuorescein (CF) from Sigma-Aldrich
(St Louis, MO), was puriﬁed as described by Ralston et al. [36] and the
hydrophobic contaminants were eliminated using an LH-20 resin. The
LH-20 resin was recovered by exhaustive washings with ethanol con-
taining 10 mM HCl until elimination of the adsorbed contaminants
and washed with pure ethanol. The recovered resin was maintained at
room temperature until evaporation of the residual solvent, stored in
the dry form, and reused when needed. The CF eluted from the LH-20
columnwas in the form of sodium salt. The CF concentrationwas deter-
mined from the absorbance at 492 nm [36] using a molar extinction
coefﬁcient of 7.5 x 104 M−1 cm−1 determined in 10 mM borate buffer,
pH 9. Other reagents were of analytical grade and were used without
further puriﬁcation. MilliQ water was used in all studies.
2.2. Methods
2.2.1. Peptide synthesis
BP100 (H-KKLFKKILKYL-NH2) was synthesized by the solid
phase method [37,38], starting from “Rink-Amide-MBHA-Resin”
(Peptides International, Louisville, KY), with a substitution degree
of 0.52 mmol.g−1. The deprotection reaction of the Fmoc group
was performed with 25% (v/v) 4-MP/DMF for 30 min (two 15 min
steps). The couplings for peptide bond formation were conducted
with DIC/Oxyma [39] in DMF during 60 to 120 min.
The deprotection and coupling reactions were monitored with
ninhydrin test [37,40]. After each deprotection and coupling step, the
resin was washed three times with 2-propanol (or methanol) and
DMF, in alternating mode. After the synthesis was completed, the ﬁnal
deprotection reaction and peptide cleavage from the resin were
performed with 10 mL of a TFA:TIPS:water (90:5:5, v:v:v) solution for
90 min at room temperature. After four washings with cold diisopropyl
ether, the supernatant was discharged and the peptide was extracted
with water and freeze-dried.
The peptide was puriﬁed by reverse-phase chromatography and
characterized by mass spectrometry. For puriﬁcation, a semi-preparative
column (Zorbax ODS 9.4 x 250 mm) from Agilent (Santa Clara, CA) was
used. The chromatograph had an LC-10 pump, an SPD-10AV UV-visible
detector, an FCV-10AL model solvent mixer unit, a DGU-14A degasser,
and a manual Rheodyne injector (Bristol, CT). All accessories were
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The gradient used was as follows: H2O:ACN:TFA (95:5:0.1, v:v:v) for
5 min, followed by a linear gradient of H2O:ACN:TFA (35:65:0.1, v:v:v)
for 60 min. The detection was performed at 216 nm and 280 nm and
the ﬂow rate was 3.0 mL.min−1, at room temperature. The identity and
purity of the peptide were veriﬁed by MALDI-ToF mass spectrometry,
using α-cyano-4-hydroxycinnamic acid as matrix. The spectra were
acquired in an Ultraﬂex III ToF-ToF (Bruker Daltonics, Billerica, MA), in
the reﬂected mode. Peptide fragmentation by MS/MS was conducted
through the LIFT™methodology [41].
Aqueous stock solutions of BP100were prepared and the concentra-
tion was determined by measuring the absorbance of Tyr at 276 nm
using a molar extinction coefﬁcient of 1,450 M−1 cm−1.
2.2.2. Preparation of small unilamellar vesicles (SUVs)
Stock solutions of different lipids in DCM or chloroformwere added,
at the desired molar ratios, to glass tubes. The solvent was eliminated
under a N2 ﬂux and remaining traces were removed in a vaccum
chamber. The dried ﬁlms were suspended, by vigorous vortexing, in
the desired aqueous solutions forming large multillamelar vesicles
(MLV). SUVs were prepared by sonication of MLVs suspension in a
G112SP1 Special Ultrasonic Cleaner, from Laboratory Supplies Company
Inc., Hicksville, NY, immersed in an ice/water bath, at 80 Watts, for
20 min. The SUVs were used to saturate the Sephadex-G25 columns
(0.8 x 20 cm) and were prepared always with the same lipid composi-
tion used in each experiment (at a total phospholipid concentration of
0.01 M) and in the same buffers used to elute the column.
2.2.3. Preparation of large unillamelar vesicles (LUVs)
Lipid ﬁlms of variable composition were prepared as described
above. The composition of the aqueous solutions used to prepare
MLVs varied according to the experiments. The MLVs were subjected
to ﬁve cycles of freeze-thawing by alternately using a bath of dry
ice/ethanol and a water bath at 37 °C followed by extrusion through
a LiposoFast extruder (Avestin Inc., Ottawa, Canada). The LUVs suspen-
sion was passed (21 passages) through two stacked membranes of
polycarbonate Nucleopore Track-Etch ﬁlters (Whatman-GE Healthcare,
Waukesha, WI) with 100 nm diameter pores, at room temperature.
For CD spectroscopy, LUVs were prepared in MilliQ water, pH 6.5, at
a ﬁnal lipid concentration of 20 mM. For NMR, LUVs were prepared in
15 mM Tris–HCl buffer, pH 7.4, containing 50 mM NaCl and 10% D2O
for lock, at a ﬁnal lipid concentration of 42.7 mM.
For the Dh and UE measurements LUVs (5 mM total lipid) were
prepared in 10 mM Tris-HF buffer, pH 8.1. Tris-HF buffer was used to
minimize electrode oxidation during the sequential measurements of UE.
In the case of PTS-loaded LUV, the lipid ﬁlms were hydrated with
0.5 mL of 1 mM PTS in water. The ﬁnal lipid concentration was
17 mM. The PTS in the buk aqueous phase was removed by eluting
ca. 0.5 mL of LUVs, on a Sephadex-G25 column (see Section 2.2.2)
with 20 mM Tris–HCl buffer, pH 8.1. LUVs were collected in 1 mL at
the column void volume (ﬁnal phospholipid concentration ca.
2 mM, see Section 2.2.5) and the pool was maintained in an ice
bath until use.
For preparation of CF-loaded LUVs, the lipid ﬁlms were hydrated
with 0.5 mL of 50 mM CF, in the sodium salt form, in 10 mM Tris–HCl
buffer, pH 8.1, yielding a ﬁnal lipid concentration of 17 mM. External
CF was removed in a Sephadex-G 25 column (Section 2.2.2) by elution
with 10 mM Tris–HCl buffer pH 8.1 and 300 mM NaCl [42]. The LUVs
were collected in 2mL, at the void volume, and the poolwasmaintained
in an ice bath until use.
2.2.4. Determination of phospholipid concentration
The phospholipid concentration in the vesicle pool collected from
the Sephadex G-25 column was determined from inorganic phosphate
analysis using an adapted method of Rouser et al. [43]. Brieﬂy, aliquots
of the vesicles pools were added to glass tubes (previously cleanedwith HCl 36 % and after with water) and the solvent completely evapo-
rated at 120 °C. HClO4 70 % was added (0.4 mL), the tubes were capped
with glass marbles and maintained in a heating block set at 180 °C for
1 h. After cooling, 1 mL of water and 0.4 mL of ammonium molibdate
1.25 % (w/v) were added to the tubes and vortexed. Then 0.4 mL of
3 % ascorbic acid (w/v) were added to each tube and vortexed imme-
diately and vigorously. The tubes were maintained in a water bath at
100 °C for 10 min. The absorbance was read at 797 nm and phos-
phate concentration was calculated using a standard curve made
with a 0.001 M KH2PO4 solution.
2.2.5. Circular dichroism studies
CD spectra were acquired at 20 °C in a Jasco J-720 spectropolarime-
ter (Tokyo, Japan). Samples were placed in 1.00 mm optical path quartz
cells. The ﬁnal spectra were the average of six scans, followed by
subtracting the spectrum obtained under the same conditions of a sam-
plewithout peptide. Spectrawere scanned from 190 to 260 nm, at a rate
of 20 nm.min−1, 1 nm resolution, 8 s time response, using 2 nm slit.
The initial peptide concentrations were 27.4 and 24.8 μM for the TFE
and membrane experiments, respectively. Spectra were acquired for
the free peptide and after addition of increasing TFE and LUV concentra-
tions. The TFE content varied from 0 to 90% (v/v) and the lipid concen-
tration from 0 to 1 mM.
The fraction of α-helical conformation acquired by the peptide was
calculated using Chen´s equation (Eq. (1), ref. [44]):
θ½ 222nm ¼ fH–ik=Nð Þ θ½ H∞ ð1Þ
where [θ]222 nm is the mean residue molar ellipticity at 222 nm;
[θ]H∞ is the mean residue molar ellipticity for an inﬁnite helix
(−39,500 deg.cm2.dmol−1); fH is the fraction of peptide in helical con-
formation; i is the number of helical segments (taken as 1 in the present
study); N is the number of residues, and k is a constant that depends on
λ, 2.57 at 222 nm.
2.2.6. NMR studies
NMR spectra were acquired in Avance III 600 and 800 MHz Bruker
spectrometers at 25 °C, using a 5 mm probe. Stock solutions of 4 mM
BP100 and 42.7mMof total lipid for the LUVswere used; the concentra-
tions of peptide and lipid in the samples are given in the captions of
Fig. 3. 1H spectra were acquired for the free peptide and after addition
of increasing LUV concentrations. Spectrawere acquiredwith 90° pulses
around 10 μs and 1.2 s of repetition delay and sweep width of 12 ppm.
All chemical shifts were referenced as described by Wishart et al. [45]
using TSP. Watergate was used for water suppression [46]. TOCSY
spectra were acquired at a mixing time of 60 ms using MLEV [47],
with a spin-lock ﬁeld of ca. 10 kHz, and spin-lock time of 60 ms.
NOESY and ROESY spectra were acquired at 100 ms mixing time.
Usually, ROESY experiments give better results when compared to
NOESY for peptides whose correlation time falls in a regime where the
product of the molecular correlation time and the Larmor frequency is
close to unity. Both TOCSY and NOESY were acquired as 4096 x 512
complex points, using Watergate for water suppression [46] and
States-TPPI for frequency discrimination in the indirect dimension.
NMRPipe was used for spectra processing and NMRView for spectral
analysis [48,49]. 13C-HSQC and 15 N-SOFAST-HMQC spectra were also
acquired using natural abundance, to help in the assignments in case
of overlap [50].
2.2.7. Dynamic light scattering, zeta potential (ζ) and electrophoretic
(UE) mobility
The values of hydrodynamic diameter (Dh), zeta potential (ζ), and
electrophoretic mobility (UE) of LUVs were determined at 30 °C, in a
quartz cuvette, using a Zetasizer Nano ZS light scattering apparatus
equipped with a 633 nm laser, from Malvern (Worcestershire, UK).
The UE was measured using a dip cell electrode. ζ was calculated from
Scheme 1. Schiffer-Edmundson helical wheel projection indicating putative polar and
apolar faces of BP100 amphipathic α-helix.
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The buffer used for vesicle dilution was previously ﬁltered through a
Millipore membrane (Billerica, MA) of 0.22 μm pore diameter. Values
of Dh and UE were the average of three independent runs. The UE
of a standard sample was measured before and after each series of
experiments to assure that the electrode sensitivity was maintained.
For the Dh and UE measurements, 25 μL of LUVs (5 mM total lipid
stock solution) were added to 1mL buffer solution, yielding a phospho-
lipid concentration of 125 μM. After measuring the initial values of Dh
andUE, aliquots of BP100 stock solutionswere added at 10min intervals
and Dh, UE, and ζ were determined.
2.2.8. PTS leakage from LUVs
PTS leakage was followed by adding 5 μL of 2 mM LUVs to 0.5 mL of
1 mMMV 14 mM Tris–HCl, pH 8.1, under stirring, at 30 °C. PTS ﬂuores-
cence emission was measured at 400 nm using λex = 350 nm. As PTS
leaks from LUVs, its ﬂuorescence decreases due to the presence of MV,
a ﬂuorescence quencher, in the external aqueous compartment. In
aqueous solution, the ﬂuorescence of 17 μM PTS decreased 85% in the
presence of 1 mM MV in solution. In the presence of LUV, BP100 was
added to the cuvette after 100 s, and the decrease in ﬂuorescence inten-
sity was recorded as a function of time. After 900 s, 10 μL of polidocanol
10% (w/w) were added to obtain complete vesicle leakage and maxi-
mum PTS quenching. The % of PTS leakage, after a deﬁned time, was
calculated according to Eq. (2):
% Leakage ¼ I0−Itð Þ
I0−Itotð Þ
x100 ð2Þ
where I0 is the ﬂuorescence intensity before addition of BP100, It is
the ﬂuorescence at a deﬁned time after BP100 addition, and Itot is the
ﬂuorescence after polidocanol addition. All ﬂuorescence measurements
were performed in a Hitachi F-2000 (Tokyo, Japan) ﬂuorimeter using a
3 mL quartz cuvette with 10 mm optical path.
2.2.9. CF leakage from LUVs
The ﬂuorescence of CF is self-quenched at high concentration. It was
possible to analyze the BP100-induced leakage of CF from LUVs bymon-
itoring theﬂuorescence increase atλem=520 nmusingλexc=490 nm,
at 700 V [51]. At zero time, an aliquot of CF-loaded LUVs (in general 5 μL
of a 2 mM lipid solution), was added to a cuvette containing 10 mM
Tris–HCl buffer, pH 8.1, 300 mM NaCl, reaching a total volume of
0.50 mL, under continuous stirring. The ﬂuorescence was continuously
recorded during 100 s; an aliquot of BP100 stock solution (200 μM, in
water) was added and the ﬂuorescence emission was followed for
3,000 s. At this time, 10 μL of polidocanol (10 % w/w) were added to
disrupt all vesicles and obtain the maximum CF ﬂuorescence. In general,
aliquots of 5 to 50 μL of BP100 (2–40 μM)were added in each experiment.
The leakage of CF was calculated making use of Eq. (3):
% Leakage ¼ It−Ioð Þ
Itot−I0ð Þ
x100 ð3Þ
where I0 is the initial ﬂuorescence intensity, before BP100 addition, It is
the ﬂuorescence at a choosen time after peptide addition, and Itot is the
ﬂuorescence after polidocanol addition. All experiments were performed
at 30 °C.
2.2.10. Optical microscopy studies of giant unilamellar vesicles (GUVs)
GUVs composed of POPC and POPC:POPG 70:30 (molar ratio) were
prepared by the electroformation method [52,53]. Few microliters of a
lipid solution in chloroform (2 mg.mL−1) were spread on the surfaces
of two glass slides coated with FTO (ﬂuorine tin oxide) and the solvent
was evaporatedwith a ﬂux of N2. The slides separated by a 2mm Teﬂon
frame were sealed to form a chamber which was ﬁlled with a 0.2 Msucrose solution. The slideswere then connected to a function generator
and an AC ﬁeld of 1 V and 10 Hz was applied for 1 h.
TheGUVswere observed byphase contrastwith a Zeiss Axiovert 200
inverted optical microscope (Jena, Germany) equipped with a 63x
objective and an AxioCam HSm digital camera from Zeiss (Jena,
Germany). A home-made observation chamber ﬁlled with a solution
of 50 μMBP100 in 0.2 M glucose was placed on the microscope stage.
A small aliquot of the GUVs suspension was added and the observa-
tion was started after few seconds. Time sequences were recorded
with the software Zeiss AxioVision. The osmolarities of the sucrose
and glucose solution were matched throughout the measurements
with a cryoscopic osmometer Osmomat Gonotec (Berlin, Germany).
Experiments were performed at 25 °C.
3. Results
3.1. Conformational properties of BP100
Although presently the secondary structure of a protein/peptide
cannot be predicted precisely based on its sequence, some dynamics
calculations allow estimating the tendency of a given sequence to attain
a speciﬁc structure. Making use of PSIPRED [54], a high tendency for
BP100 to acquire helical conformation was predicted (not shown).
According to the Schiffer-Edmundson helical wheel projection [55],
BP100 could form an amphipathic α-helix as depicted in Scheme 1.
OCD and solid-state 15 N NMR data indicated that the BP100 helix is
oriented roughly parallel to the membrane surface [34]. This observa-
tion was corroborated by calculating the peptide mean hydrophobicity
(bHN) and mean hydrophobic moment (bμHN) making use of the
formalism of Eisenberg et al. [56] for an amphipathic α-helix. The
values of b H N and b μH N were found to be, respectively, −0.23
and 0.52, which characterizes BP100 as a surface-seeking amphipathic
α-helix [56].
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To assess the conformational properties of BP100 in solution and
upon binding to bilayers, we performed a comprehensive study of the
peptide CD spectra as a function of lipid composition and lipid:peptide
molar ratio. The far-UV CD spectrum of BP100 in aqueous solution
exhibited a negative band centered at 197 nm, indicating that the pep-
tide exists as an equilibrium of conformations (Fig. 1A). The spectra
remained unchanged with peptide concentration (10 to 100 μM),
suggesting that BP100 did not aggregate in this concentration range
(not shown).
The tendency of a peptide to acquire secondary structure can
be evaluated by addition of a structure-inducing agent, e.g. 2,2,2-
triﬂuoroethanol (TFE) [57–59]. Increasing TFE concentration led to
changes in the CD spectra of BP100, suggestive of a more ordered
conformation (Fig. 1A). After saturation (≥40% TFE, Fig. 1B), the
spectrum is characterized by a positive band at 192 nm and two
negative bands at 207 and 222 nm, indicating that the peptide
adopted α-helical conformation, in agreement with the PSIPRED pre-
diction. At 90% TFE, making use of Chen´s equation [44] (seeMaterials
and Methods), we calculated that ca. 5 residues are in α-helical
conformation.
The partitioning ofmembrane-active peptides intomembrane inter-
faces favors formation of hydrogen bonds and acquisition of secondary
structure [60]. No signiﬁcant changes were observed in the CD spectra
of 24.8 μM BP100 upon adition of POPC LUVs, at peptide:lipid ratios
ranging from 1:1 to 1:40 (not shown). In contrast, considerable spectral
changes took place in the presence of POPC:POPG LUVs, indicative of a
more ordered structure. The positive band around 196 nm and theFig. 1. Far-UV CD spectra of 27.4 μMBP100. A. TFE content (v %): 0 (■), 20 ( ), 40 ( ), 60
( ), and 80 ( ); B. Modulus of [θ] at 222 nm as a function of TFE (v %).two negative bands, around 208 nm and in the 220–230 nm region
(Fig. 2A, C, E, and G) showed that BP100 acquired α-helical conforma-
tion upon binding to POPC:POPG bilayers, pointing to the importance
of electrostatic interactions for membrane binding, as noted by Ferre
et al. [28].
Spectra were obtained as a function of lipid concentration for LUV
containing the following POPC:POPG molar ratios: 75:25, 50:50, 25:75,
and pure POPG (Fig. 2A, C, E, and G). CD spectra of membrane-bound
BP100 for a limited range of lipid compositions and peptide:lipid
molar ratios have been reported [27,32,33]. In general, a gradual
increase of α-helical conformation was observed upon increasing
lipid concentration (Fig. 2). The spectral features also varied with
POPC:POPG molar ratios. Several spectra displayed features typical
of membrane-bound peptides, namely, a shift to longer wavelengths
and a decreased intensity of the band at 208 nm with respect to that
in the 220–230 nm region. These features have been extensively
related to differential absorption ﬂattening and differential light
scattering due to aggregates present in the sample [61–63]. Making
use of Chen´s equation [43], we found that ca. 6 residues of BP100
are in α-helical conformation upon binding to POPC:POPG 50:50
bilayers, a number close to that obtained in 90% TFE (see above).
This result is in agreement with the CD studies in ref. [34].
The panels on the right of Fig. 2 (Fig. 2B, D, F, and H) display the
wavelengths at which minimum [θ] values ([θ]min) were observed in
the 220–230 nm range (λθmin), as well as the calculated charge of the
(peptide + lipid) system assuming a + 6 charge for the peptide.
For POPC:POPG molar ratios of 75:25 and 50:50 (Fig. 2A and C), λθmin
red-shifted to amaximumwavelength in the region of electroneutrality
of the system, decreasing thereafter. For POPC:POPG 25:75 and pure
POPG (Fig. 2F and H), λθmin red-shifted to a maximum close to elec-
troneutrality, but, in contrast to the former cases, this wavelength
remained essentially constant even when the system’s total charge
was considerably negative.3.1.2. NMR studies
To analyze the conformational properties of BP100 at greater molec-
ular detail, we did NMR studies of the peptide in the presence of LUVs of
PC and PC:PG by adding excess ligand (BP100). When the equilibrium
between free and bound ligand is faster than the time necessary to
build up NOEs (milliseconds), it is possible to obtain the NOEs of the
bound state (as described in ref. [64]). These NOEs enabled structure
determination of the bound peptide, without any prior knowledge of
the structural features of the lipid bilayer. We have previously used
this method to study peptide-membrane interaction [65,66].
BP100 resonanceswere sequentially assigned using the combination
of TOCSY and ROESY spectra. Usually for small peptides, NOEs at the
laboratory frames can be zero, while NOEs at the rotating frame,
from ROESY experiments, give non-zero correlations. Sequential
αN(i, i + 1) NOEs at the rotating frame were clear for many residues.
When sequential NOEs were absent, the typical TOCSY pattern of
each aminoacid residue was used. 13C-HSQC and 15 N SOFAST-HMQC
spectra were also acquired using natural abundance; this was impor-
tant to overcome 1H chemical shift overlaps. The backbone atoms of
most residues, with the exception of K1 and K2 were assigned. A partial
assignment is summarized in Table 1.
The one-dimensional 1H spectrum of BP100 was obtained by pre-
saturating water for 1.5 s, at different concentrations of BP100 and
LUVs (Fig. 3A). Because of the lack of stable secondary structure of
BP100, the peptide amidic hydrogens were saturated in the presence
of PC LUVs. When the membranes contained PG, the amidic hydrogens
were more protected from exchange with water and their NMR signal
was less attenuated by water pre-saturation, indicating that these
hydrogens were involved in hydrogen bonding. This is a strong indica-
tion of structure acquisition due to peptide binding to PC:PG LUVs,
in agreement with CD data.
Fig. 2. Left: Far-UV CD spectra of 24.8 μMBP100 in the presence of increasing concentrations of POPC:POPG LUVs of variable composition.A. 75:25; C. 50:50; E. 25:75;G. pure POPG. Total
lipid (μM): 0 (■); 100 ( ); 150 ( ); 250 ( ); 500 ( ); 1000 ( ). Thepeptide:lipidmolar ratioswere 1:4, 1:6, 1:10, 1:20, and 1:40, respectively. Right:Wavelength (λ) of thenegativepeak
in the 220–230 nm region (□) and calculated total charge of the peptide + lipid system (■), assuming total binding and a charge of +6 for the peptide.
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Table 1
Partial Resonance Assignments of BP100 at 25 °C, pH 7.4. Values displayed in ppm and
referenced as described by Wishart et al. [44].
N HN Cα Hα Cβ Hβ Hγ Cδ Hδ
L3 127.6 8.33 4.36 42.5 1.51
1.60
24.8 0.926
F4 122.4 8.34 4.36 3 9.7 3.01
3.10
K5 124.6 8.32 54.7 4.38
K6 125.5 8.16 56.1 4.26
I7 123.8 8.26 60.8 4.15 38.5 1.85 1.18 12.6 0.864
L8 127.6 8.33 4.36 42.5 1.51
1.60
23.5 0.859
K9 8.27 4.25 1.73
Y10 121.7 8.20 57.7 4.58 42.0 3.00
L11 122.3 8.17 4.25 30.0 1.52
1.59
17.47 0.878
Fig. 4. Secondary structure plot. Summary of ambiguous transfer NOEs observed
for BP100 in the presence of 90:10 PC:PG LUVs. Solid lines reﬂect strong and medium
intensity NOEs and dashed lines indicate weak NOEs.
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(Fig. 3B). The spectra of BP100 in aqueous solution did not show NOEs
at 100 ms mixing time; due to the high peptide ﬂexibility, only very
low intensity NOEs, indistinguishable from intraresidual ones, could
be observed. A similar behavior was observed in the presence of pure
PC LUVs, indicating that the peptide did not bind signiﬁcantly to these
vesicles. In the presence of PG-containing LUVs, a signiﬁcant number
of transfer NOEs was observed, again pointing to structure acquisition
upon binding to these LUVs. This spectrum indicated the presence of
NOEs typical of α-helical conformation for BP100 in the presence of
90:10 PC:PG LUVs (Fig. 4). The number of NOEs, as well as the intensity
of the 1H spectrum, decreased upon increasing the PG content from
90:10 to 70:30 PC:PG.
3.2. Effect of BP100 on the hydrodynamic diameter, Dh, and zeta potentials,
ζ, of LUVs containing variable PC:PG molar ratios
The Dh´s of pure PC LUVs in 0.01M Tris-HF, pH 8.1, did not vary upon
addition of BP100 (Fig. 5). In contrast, strong effects were observed forFig. 3. NMR spectra of BP100 upon interaction with LUV. Amidic region of the one-dimension
buffer, pH 7.4, 50 mM NaCl, in the presence of LUVs: Panels A and D show the results obtained
show the results obtained with 2 mM PC:PG 70:30 molar ratio. BP100 concentrations (µM) for
were acquired with 800 μM BP100 concentration. Note that transfer NOEs only appear when
weight contaminant in the LUVs that appears in all spectra.PC:PG LUVs probably due to the electrostatic interaction between the
positively (+6) charged peptide and negatively charged PG. The initial
Dh of LUVs of variable PC:PGmolar ratios was 95± 10 nm (Fig. 5), with
a polydispersity index (PDI) b 0.1. The PDI remained b 0.1 with increas-
ing BP100 concentration until electroneutrality, where both Dh (Fig. 5A)
and PDI increased considerably, indicating vesicle aggregation, as sug-
gested by the CD data (Fig. 2). It is noteworthy that between 3 μM and
6 μM BP100, the Dh of vesicles containing PG molar ratios of 30% and
higher increased to ca. 140 nm (Fig. 5B), remaining approximately
constant until electroneutrality.
For LUVs of pure PC, the initial values of ζ were, respectively,
ca. -10 mV and −1 μm.cm/V.s (Fig. 6). Differential ion binding
to zwitterionic phospholipids could be responsible for the small
negative potential of the PC LUVs [67–70]. Addition of BP100 to 90:10
and 80:20 PC:PG LUVs caused a continuous decrease in the absolute
values of ζ (Fig. 6A). Increasing the PGmolar ratios produced extremely
different results in the ζ vs BP100:lipid ratio patterns. A clear plateau,al 1H-spectra (A, B and C) and 2D NOESY spectra (D, E and F) of BP100 in 15 mM Tris:HCl
with 5 mM PC; B and E show the results with 2 mM PC:PG 90:10 molar ratio; and C and F
the 1D spectra were 100 (top spectra), 400 (middle), and 800 (bottom). 2D experiments
PG is present. The peak at 8.35 ppm in panels A, B, and C corresponds to a low molecular
Fig. 5. Dh of LUVs at variable PC:PGmolar ratios. Pure PC (⃝ ); 90:10 (●); 80:20 (△); 70:30 (▲); 60:40 (▽); 50:50 (▼); 30:70 (□) 20:80 (■); 10:90 (⃟ ) pure PG (♦). Left: the ordinate
scale ranges from 0 to 2,000 nm. Right: the ordinate scale ranges from 0 to 180 nm. Total lipid concentration, 125 μM, 10 mM Tris-HF buffer, pH 8.1.
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evident as the PG molar ratio increased (Fig. 6A and B). This behavior
became much more pronounced for vesicles containing higher PG
proportions. After reaching a plateau,where the value of ζwas indepen-
dent of peptide: lipid molar ratio, further increasing this ratio produced
a sharp decrease in the absolute value of ζ. The BP100:lipid ratio where
this sharp increase of ζ occurred varied as a function of PC:PG molar
ratio (Fig. 6A and B). In general, values of ζ near zero were obtained at
PG concentrations approximately six times that of BP100, as observed
by Freire et al. [71]. In the region close to ζ ≅ 0 there is high data
dispersity probably due to BP100-induced aggregation of LUVs.
3.3. BP100-induced leakage of LUVs containing variable PC:PG molar ratios
We investigated the peptide effect on the leakage of ﬂuorescent
probes incorporated in the inner aqueous compartment of LUVs.
The conformational studies (Section 3.1) and the measurements of
hydrodynamic diameter and of ζ (Section 3.2) provided clear evi-
dence for the importance of electrostatic interactions on peptide
binding. Therefore, we examined the effect of ionic strength on
BP100-induced leakage.
For studies at low salt (20 mM Tris–HCl, pH 8.1), leakage was
monitored using the PTS/MV system (see Section 2.2). The effect of
BP100 concentration on PTS leakage was studied with LUVs prepared
at several PC:PG molar ratios as a function of time.
In the absence of BP100, LUVs of pure PC containing PTSwere stable
and the PTS leakage after 15 min was ca. 3 % (not shown). Fig. 7AFig. 6. Zeta potential as a function of BP100 concentration for LUVswith variable PC:PGmol
50:50 (▼); 30:70 (⃞ ); 20:80 (■); 10:90 (⃟ ); pure PG (♦). Total lipid concentration: 125 μM,presents the effect of varying BP100 concentration on PTS leakage
from LUVs containing PC:PG 50:50 as a function of time, at a ﬁxed LUV
concentration. With PC:PG 50:50 LUVs, without BP100, the PTS leakage
after 15 min was ca. 12 %, showing that vesicles containing negatively
charged PG were more leaky, possibly due to charge repulsion be-
tween phospholipids (Fig. 7A, line a). It is likely that MV outside
the LUVs containing PTS also contributes to vesicle destabilization
due to binding of the MV di-cation to PG. BP100 addition to 50:50
PC:PG LUVs caused a peptide concentration-dependent decrease in
PTS ﬂuorescence (Fig. 7A).
In the presence of BP100, the kinetics of PTS leakage (Fig. 7A) were
more complex at the lower peptide:lipid molar ratios; the shapes of
the curveswere differentwith increasing BP100 (compare, for example,
curves c and f in Fig. 7A) suggesting changes in mechanism and/or rate
limiting steps of leakage.
The extent of peptide-induced leakage as a function of BP100:lipid
ratios with LUVs at several PC:PG molar ratios was compared by
analyzing the percentage of leakage at a ﬁxed time (850 s) and LUV
concentration (Fig. 7B). As an example, the % leakage for each
BP100 concentration, at 850 s, with PC:PG 50:50 LUVs (Fig. 7A),
was calculated and plotted vs BP100:lipid molar ratio (Fig. 7B).
Each line in Fig. 7B corresponds to LUVs of different PG:PGmolar ratios
andwas constructed from sets of data similar of those in Fig. 7A. Clearly,
the BP100 concentration required for 50% leakage decreased with
increasing PG content in LUVs (Fig. 7B).
In order to clarify the inﬂuence of the PG content on LUVs perme-
ability, the percentage of PTS leakage, at a ﬁxed BP100:lipid molarar ratio.A. Pure PC (⃝ ); 90:10 (●); 80:20 (△); 70:30 (▲); 60:40 (▽). B. PC:PGmolar ratio
10 mM Tris-HF buffer, pH 8.1.
Fig. 7. A. PTS leakage from LUVs upon addition of BP100 at low ionic strength. A.
Leakage of PTS from 50:50 PC:PG LUV as a function of time for increasing BP100
concentration (μM): a) zero; b) 0.25; c) 0.50; d) 0.75; e) 1.25; f) 1.42; g) 2.50. B. Effect
of peptide:lipid molar ratio on PTS leakage, after 850 s. PC:PG 90:10 ( ⃝ ); PC:PG 85:15
(●); PC:PG 70:30 (△); PC:PG 50:50 (▲); PC:PG 30:70 ( ⃞ ); pure PG (■). C. PTS leak-
age as a function of PG content at BP100:lipid molar ratio of 0.08, at 850 s. Total lipid
concentration, 17.8 μM, 14 mM Tris–HCl, pH 8.1, MV concentration, 1 mM.
Fig. 8. CF leakage from LUVs upon addition of BP100. A. Leakage from 50:50 PC:PG LUV
as a function of time for increasing BP100 concentration (μM): a) zero; b) 0.84; c) 1.26;
d) 1.98; e) 3.42; f) 6.84. B. Effect of peptide:lipid molar ratio on leakage, after 2,400 s.
PC:PG 90:10 (⃝ ); 80:20 (●); 70:30 (△); PC:PG 50:50 (▲); PC:PG 30:70 (▽); pure PG
(▼). C. Leakage of CF as a function of PG content at a BP100:lipid molar ratio of 0.2 after
2,400 s. Lipid concentration, 18 μM, 10 mM Tris–HCl buffer, pH 8.1, 300 mM NaCl.
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(Fig. 7C). As can be observed in Fig. 7C, the percentage of PTS leakage
increased sigmoidally with increasing PG content.
To analyze the effect of higher ionic strength on BP100-induced leak-
age, LUVswere loadedwith 50mMCF and the external buffer contained
10mMTris–HCl, pH 8.1, and300mMNaCl (see Section 2.2). Addition ofBP100 to LUVs at this salt concentration did not lead to vesicle aggrega-
tion, in contrast to the experiments performed at low ionic strength,
where aggregation was observed in some samples.
LUVs of pure PC were very stable at high ionic strength; after ca.
30 min, only 1.5% leakage was detected (not shown). Addition of
2.5 μM BP100 to PC LUVs induced ca. 15% leakage after 40 min, indicat-
ing a small BP100 effect (not shown). Fig. 8A shows the time course of
CF leakage from a ﬁxed concentration of 50:50 PC:PG LUVs as a function
of BP100 concentration. Although the leakage rates were slower at
higher ionic strength, the kinetic proﬁles were similar to those obtained
1994 M.C. Manzini et al. / Biochimica et Biophysica Acta 1838 (2014) 1985–1999at low ionic strength (Fig. 7A). The kinetics were also more complex
at the lower peptide:lipid molar ratios (e.g., compare curves c and f
in Fig. 8A).
The effect of BP100:lipid ratios and PG content was compared at
2400 s, at the same LUV concentration (Fig. 8B). Each curve in Fig. 8B
corresponds to different PC:PG molar ratios and was obtained from a
set of experiments similar to those in Fig. 8A. The BP100 concentration
required for 50% leakage also decreased with increasing PG content
(Fig. 8B). The CF leakage as a function of PG content at a 0.2 BP100:
lipid ratio, time (2,400 s), and LUV concentration is shown in Fig. 8C;
clearly, as seen at low ionic strength (Fig. 7C), leakage also increased sig-
moidally with increasing negative charge.
The effect of ionic strength on LUVs leakage was evaluated by
comparing the leakage of LUVs of PC:PG 50:50 at a ﬁxed time
(800 s) and very similar total lipid concentration (17.8 μM and
18 μM, Fig. 9) as a function of BP100:lipid molar ratio. Increasing
the BP100:lipid molar ratio increased leakage at both low and high
ionic strength. However, the BP100:lipid molar ratios producing
50% leakage were very different, i.e., 0.023 at low and 0.16 at high
ionic strength. Fifty percent leakage required ca. 7 times more
BP100 at the higher ionic strength.
3.4. Optical microscopy of GUVs in the presence of BP100
The effects of BP100 on GUVs of POPC or POPC:POPG (70:30 molar
ratio) were examined using phase contrast optical microscopy. GUVs
in the absence of peptide were stable under the microscope and
retained the sugar asymmetry for, at least, four hours of observation,
which is the time scale of the experiments. An aliquot of a GUV suspen-
sion was added to an observation chamber containing a 50 μM BP100
solution and individual GUVs were selected and followed with time.
The peptide effect on GUVs of POPC:POPG (Fig. 10A) and POPC
(Fig. 10B) was dependent on membrane charge. POPG-containing
GUVs were observed to burst in the presence of peptide, as shown
for two GUVs in Fig. 10A (at 551 s and 570 s). Bursting was character-
ized by a fast (within less than a second) collapse of the GUV into
dense peptide-lipid aggregates (see last snapshot at 570 s). Several
dense patches (indicated with arrows in Fig. 10A) were often observed
on the surface of both vesicles before the ﬁnal bursting event. The for-
mation of these dense regions is also induced by other antimicrobial
peptides, such as gomesin [53] and MPX [72], and has been interpreted
as arising from a local membrane bending mediated by the peptides,
which would act as linkers between apposed layers. Therefore, these
regions, which are similar to the remains after vesicle burst, indicate aFig. 9. Effect of BP100:Lipid ratio on the leakage of CF and PTS. (●) CF in 10 mM
Tris–HCl buffer, pH 8.1, 300 mM NaCl and (⃝ ) PTS in 14 mM Tris–HCl, pH 8.1, and 1 mM
MV. The membrane consisted of 50:50 PC:PG and the total lipid concentration was 17.8
and 18 μM for LUVs with PTS and CF, respectivelly. All data were obtained after 800 s.dense peptide-lipid aggregate. The occurrence of this phenomenon
could be analogous to BP100-induced vesicle aggregation observed
with LUVs (see Fig. 5).
Different effects were observed for GUVs of pure POPC. Even though
some GUVs burst in a manner similar to that seen in Fig. 10A, many
vesicles remained intact but lost their optical contrast, conferred
by the original sucrose/glucose asymmetry. Fig. 10B shows one such
example. Dense patches were also observed on the surface of the
GUVs (see arrows in Fig. 10B). After 440 s, the GUV began to lose its
optical contrast, which was completely lost after 540 s. Even after long
contact times with the peptide solution (15 min), many GUVs were
still stable, although without the original optical contrast. These results
indicate that BP100 is able to permeabilize POPC GUVs without
disrupting the vesicle. It should be noted that high peptide concentra-
tions and low lipid concentrations were used in this study. Moreover,
although no acquisition of secondary structure was detected by CD or
NMR, the peptide did have a small effect on the zeta potential (Fig. 6)
and leakage (Fig. 7) of PC LUVs, both at low (not shown) and high
(Fig. 8B) ionic strength. These results are in accordance with the effects
observed in pure POPC GUV.
4. Discussion
Weexamined the conformational properties of BP100 in the absence
and presence of model membranes using theoretical approaches, as
well as CD and NMR spectroscopy. The effect of BP100 upon structural
and functional properties of the membranes was investigated by
measuring hydrodynamic diameter, zeta potential, and leakage of LUVs
inner contents at low and high ionic strength. The peptide-membrane
interaction was also monitored by means of optical microscopy of
giant unilamellar vesicles (GUVs). This multiple approach provided a
detailed picture of the events taking place upon the salt-dependent
BP100-bilayer interaction and demonstrated that the peptide´s
mechanism of action depends on peptide:lipid ratio and membrane
surface charge.
4.1. Conformational properties of BP100
Theoretical prediction [54] and calculation of the mean hydropho-
bicity and mean hydrophobic moment according to Eisenberg et al.
[56] revealed that the peptide displays a propensity to fold as a
surface-seeking amphipathic α-helix, with a polar angle of 180°, as
shown by OCD and solid state NMR studies [34]. Interestingly, the
helix polar surface consists of ﬁve lysine residues, K1, K2, K5, K6,
and K9 (Scheme 1), giving rise to a curved surface with a 1.2 nm
length covered by ﬁve positive charges, plus the N-terminus, allowing
the interaction with negative charges on the membrane surface.
CD and NMR spectra showed that, upon binding to LUV containing
negatively charged PG, BP100 acquired α-helical conformation.
Peptide binding to zwitterionic PC membranes was not detected by
CD or NMR, emphasizing the importance of electrostatic interactions
for BP100-membrane interaction. It should be noted, however, that
small effects of BP100 were observed in the studies of zeta potential
(Fig. 6) and vesicle leakage (Figs. 7 and 8). Moreover, BP100 exerted
an effect on GUV of pure PC (Fig. 10). Since it has been extensively
shown both experimentally [67–70] and by molecular dynamics [73]
that zwitterionic PC bind ions, it is conceivable that BP100 binds to
pure PC LUVs to a small extent, not enough to allow the detection
by CD or and NMR . In addition, weak binding may be related to a
shallower peptide location, not sufﬁcient to promote achievement
of secondary structure.
When LUVs contained negatively charged PG, BP100’s CD spectral
features depended on both peptide:lipid ratio and PG content.
For POPC:POPG molar ratios of 75:25 and 50:50 (Fig. 2A and C), the
wavelength of [θ]min was red-shifted to a maximum, decreasing there-
after. It is noteworthy that this maximum occurred in the region close
Fig. 10. Phase contrast opticalmicroscopy ofGUVs in the presence of 50μMBP100.A.POPC:POPG (70:30,molar ratio);B. Pure POPC. The time on top of each snapshot refers to the time
elapsed after addition of an aliquot of GUVs to the observation chamber ﬁlled with 50 μM peptide solution. The arrows indicate dense spots formed on the surface of the GUVs. The scale
bars represent 10 μm.
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POPG (Fig. 2E and G), the wavelengths of [θ]min were also red-
shifted to a maximum wavelength when the system’s charge was
close to electroneutrality, but, in these cases, these values remained
essentially constant even when the system’s total charge was
considerably negative.
The red shifts were probably due to peptide-induced vesicle
aggregation, a condition favored by electroneutrality. For the lower
PG contents, the red shift tended to disappear with increasing total
lipid content, which leads to an increase of the system’s total (negative)
charge, suggesting that charge repulsion reversed aggregation. Vesicle
aggregation under conditions close to electroneutrality was conﬁrmed
by quasielastic light scattering (Section 4.2). However, the fact that
the wavelengths of [θ]min remained red-shifted with increasing vesicle
concentration suggested that aggregation persisted even at high lipid:
peptide ratios for membranes containing high PG proportions. Since it
does not seem realistic that vesicle aggregation would persist under
conditions where the system’s total charge becomes considerably
negative (Fig. 2B, D, F, and G), it is conceivable that at these high PG
molar ratios the peptide is capable of promoting lipid clustering, giving
rise to areas of high peptide density. In these latter cases peptide aggre-
gation on themembrane surface would be responsible for the observed
red shifts of [θ]min. Subsequently, peptide-rich patches might be able to
leave the bilayer, causing membrane disruption, which would explain
the irreversibility of [θ]min red shifts. As discussed below, this rationali-
zation was validated by the results obtained in leakage experiments
(Section 4.3) and in studies with GUV (Section 4.4).
Further analysis of the CD spectra also substantiates the notion of
vesicle disruption for membranes with high PG content. An examina-
tion of Fig. 2 left panels (Fig. 2A, C, E, and G) reveals that in several
spectra the negative band at ca. 208 nm becomes less intense than the
band in the 220–230 nm region. This behavior, which is also an indica-
tion of aggregation, parallels the red shifts depicted in the right panels of
the ﬁgure. As discussed above, it seems unlikely that the asymmetry
in intensity of the two peaks would be due to vesicle aggregation
remaining under conditions of considerable negative charge of the
(peptide + lipid) system (Fig. 2B, D, F, and G). These spectral fea-
tures observed for 25:75 POPC:POPG and pure PG represent addi-
tional evidence for peptide aggregation on the membrane surface,
as well as peptide-induced lipid clustering. Membrane disruption
could follow, giving rise to peptide-rich membrane fragments. Similar
events have been described for the parent peptides melittin [74],
cecropin [75], and for other hybrids of these peptides [23].
The leakage studies showed that, while peptide-induced leakage
was relatively slow for vesicles of lower PG content, at all peptide:lipid
ratios, leakage was, in our time-scale, essentially instantaneous in
the case of vesicles with higher PG content, especially at the higherpeptide:lipid ratios. Thus, the features observed in the CD spectra
(red shifts and lesser intensity of the peak centered at ca. 208 nm) for
samples with higher PG contents would be due either to peptide high
concentration in clusters, giving rise to highly leaky vesicles, or to vesi-
cle disruption, or both phenomena occurring sequentially. On the other
hand, lipid clustering would not occur in membranes with lower PG
content, or would occur to a low extent, in a time-dependent process.
Although the experiments were not performed under similar condi-
tions, vesicle disruption and formation of peptide-lipid dense regions
were observed with GUVs (Section 4.4).
BP100-promoted lipid clustering was not detected in calorimetric
experiments with phosphatidylethanolamine (PE):cardiolipinmem-
branes at 75:25 molar ratio [33]. Although this lipid composition
is different from those used in the present study, the results of
Wadhwani et al. [33] agree with the present data that suggest that
clustering does not occur to a signiﬁcant extent in membranes with
lower PG contents.
As for theNMRdata, transfer NOEs can beused to calculate the struc-
ture of bound BP100. However, we decided not to conduct direct struc-
tural calculations for BP100 in the presence of PC:PG LUVs since the
resonances were highly ovelapped in the transfer NOESY spectra and
the NOEs were ambiguous. Nevertheless, since CD indicated that a
helical structure was stabilized in the presence of PC:PG LUVs (Fig. 2),
we made use of these data to analyze the NMR data. Thus, we decided
to look for answers to two important questions: (i) what type of helix
is stabilized? (ii) which residues are involved in helix formation? An
examination of the transfer NOESY spectrum indicated the presence of
NOEs typical of α-helical conformation for BP100 in the presence of
90:10 PC:PG LUVs (Fig. 4). NOEs for an α-helix spanning residues L3 to
L11 were deduced together with αN(i, i + 3) and αβ(i, i + 3) for all
residues in this region and two αN(i, i + 4) that are present only for
α-helices. Residues K1 and K2 were not assigned. This analysis yields a
higher α-helical content than that calculated from the CD spectra.
Very likely, this difference is inﬂuenced by the effect of vesicle aggrega-
tion on the CD spectra. Moreover, according to Manning et al. [76], the
minimumhelix length required to produce anα-helix-like CD spectrum
is two to three turns (seven to eleven residues). It is conceivable that
BP100 is not sufﬁciently long to yield CD spectra corresponding to the
actual helix length.
The number of NOEs, as well as the intensity of the 1H spectrum,
decreased upon increasing the PG content from 90:10 to 70:30 PC:PG,
indicating an increase in binding afﬁnity with increasing PG content.
At 70:30 PC:PG molar ratio, conditions for transfer NOE were not ideal
because of the increase in binding afﬁnity and consequent slower
exchange regime. The decrease in signal intensity is attributable to
broader 1H lines. Increased peptide binding with increasing PG content
is in agreement with the leakage studies (Section 4.3).
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Quasielastic light scattering data showed that, while the hydrody-
namic diameter (Dh) of PC LUVswas essentially constant in the presence
of BP100, addition of the peptide to PG-containing LUVs at low ionic
strength caused signiﬁcant effects onDh (Fig. 5A). At higher peptide con-
centrations, and for all PG contents, Dh and PDI increased considerably,
indicating vesicle aggregation, as suggested by the CD data (Fig. 2).
The results obtained for zeta potential measurements (Fig. 6) can be
rationalized by assuming that in LUVs containing less than 30 mole %
PG, the phospholipid negative charges are well separated and only a
small fraction of buffer ions bind to the membrane surface. In fact, the
limit of ca. 30% surface charge necessary for ion condensation and stabil-
ity of charged particles with little electrostatic repulsion at the interface
is well known [77,78]. Addition of the peptide leads to charge neutrali-
zation with a continuous decrease in ζ.
The data in Fig. 6B clearly show that, although the peptide does bind
to the LUVs upon addition of the initial BP100 aliquots, the zeta poten-
tial of the vesicles in this region remains constant. The most likely and
simplest explanation for this observation considers that the stability of
several aggregated systems depends on a constant surface potential. In
order to maintain a constant surface potential, binding of positively
charged molecules has to be compensated by displacement of counter-
ions bound to the negatively charged headgroups. Our data do not allow
a distinction between the enthalpic (coulombic) and entropic compo-
nents that determine the stability of the aggregated system with con-
stant surface potential and the measurement of zeta potential cannot
inform on hydrophobic binding.
For LUVs containing N30 mole % PG, the average distance between
the PGmolecules decreases, and repulsion increases, potentially decreas-
ing vesicle stability, particularly at low ionic strength. Charge repulsion,
due to proximity of like-charged groups at the interface in vesicles and
other amphiphilic aggregates, decreases by counterion condensation
leading to lower free energy and aggregate stabilization [79]. In PG-
containing LUV, condensation of Na+ and TrisH+ counterions at the sur-
face contribute to vesicle stabilization by neutralizing part of the negative
charge [80]. The positively charged BP100 can ion-exchange, displacing
bound cations and maintaining the total vesicle charge [81]. Ion ex-
change is the most plausible explanation for the regions of Fig. 6 where
the ζ essentially does not vary with increasing BP100:lipid ratio. It is
noteworthy that in the region between approximately 3 μM and 6 μM
BP100, the size of vesicles, containing PGmolar ratios of 30% and higher,
increased to ca. 140 nm (Fig. 5B), and remained approximately constant
until electroneutrality, suggesting that peptide binding at low BP100:
lipid ratios promotes an increase in vesicle size. This behavior suggests
that the vesicle charge only changes appreciably after interfacially
bound counterions are exchanged for BP100. The residual negative vesi-
cle charge can then be completely neutralized by further peptide addi-
tion. At this point, the values of electrophoretic mobility do not reﬂect
the mobility of isolated vesicles due to vesicle aggregation (Fig. 5A).
The fact that electroneutrality was achieved at a ca. 1:6 BP100:PG
molar ratio strongly suggests that both the outer and inner bilayer leaf-
lets are accessible to the peptide. In fact, it was reported that BP100 can
translocate across model membranes [28]. In addition, experiments
with GUVs (Section 4.4) showed that membrane disruption can occur
in the presence of BP100. Although experiments with GUVs have not
been performed in conditions similar to those of ζmeasurements, the
possibility of membrane disruption in the latter experiments should
also be considered, especially at the higher PG contents and high
peptide:lipid ratios. Disruption of E. coli cell envelope was reported by
Alves and coworkers [26].
4.3. Effect of BP100 on leakage of vesicle inner contents
Since the interaction between positively charged peptides and the
lipid components of membranes is strongly determined by electrostaticinteractions, and since physiological media contain several charged
species, we found it important to examine the effect of ionic strength
on BP100-membrane interaction. Studies with PG-containing LUVs
were performed at low (Fig. 7) andhigh (Fig. 8) ionic strength. The leak-
age kinetics depended on peptide:lipidmolar ratio, beingwere complex
at lower peptide:lipid molar ratios. The shapes of the kinetic curves are
distinctly different with increasing BP100, suggesting possible changes
in mechanism [82].
A quantitave comparison between the data at low and high ionic
strength is not straightforward. However, an analysis of the data at
ﬁxed times provided an estimate of maximum ionic strength effects.
Fig. 9 shows that, at BP100:lipid, addition of 0.3 M salt decreased the
efﬁciency of the leakage processes seven fold. Ben-Tal and coworkers
[83] also found an ionic strength dependence of the binding of
pentalysine to membranes containing negatively charged phospholipids.
In view of the several events occurring upon BP100 interaction with
charged vesicles, the determination of an ion exchange constant would
be more appropriate to analyze this interaction at high ionic strength.
Nevertheless, at low ionic strength an ion exchange constant as
well as a binding constant can be used to characterize the system
in conditions of minimum screening of electrostatic interactions [84].
The calculated total charges (in μM) of the (peptide + PG) systems
in Fig. 7A are: −7.5, −6.8, −6.0, −4.5, −1.5, −0.5, and +6.0
(for curves a-g). Thus, the change in kinetic behavior takes place as
the system approaches electroneutrality. Furthermore, as the PG con-
tent increased, the BP100 concentration required to reach 50% leakage
decreased. Assuming the vesicle radius to be 50 nm, and the lipid
cross section as 0.7 nm2, we estimated the number of lipid molecules
per vesicle to be approximately 86,000. For the data in Fig. 7B, we esti-
mate that, in order to obtain 50% leakage, approximately 1.1 x 104
BP100 molecules are required per vesicle of PC:PG 70:30, whereas ca.
3,000 are required per vesicle of PC:PG 50:50, 2,000 per vesicle of PC:
PG 30:70, and 900 per vesicle of pure PG. This suggests that the process
is of cooperative nature, being strongly favored by increasing themem-
brane PG content. The cooperativity of the process is corroborated by
the data in Figs. 7C and 8C,where the percentage of leakage is presented
as a function of PG content. These results are in agreement with the
ﬁndings of Mosior and MacLaughlin [85] and Ben-Tal et al. [83] who
also found that the binding of pentalysine to membranes containing
negatively charged phospholipids is of cooperative nature.
An additional remark concerns the fact that, although the interaction
between BP100 and negatively charged membranes decreases at
high ionic strength, binding still occurs to a considerable extent,
indicating that other forces also contribute to binding. The hydro-
phobic nature of the residues in the apolar face of the amphipathic
α-helix formed by BP100 (Scheme 1) very likely plays an important
role in the hydrophobic contribution for peptide binding.
4.4. Effect of BP100 on GUV
The opticalmicroscopy observations of GUVs agreedwith the results
obtained for LUVs, indicating that the effects of BP100 on membranes
were modulated by surface charge. While BP100 induced bursting of
negatively charged GUVs, membrane permeabilization without vesicle
disruption was observed with PC GUVs (Fig. 10). Although the experi-
mental conditions employed with GUVs are different from those used
in experiments with LUVs (the peptide:lipid molar ratio is much higher
and the lipid concentration is much lower), small effects were observed
on ζ (Fig. 6) and on the extent of leakage of pure PC LUV upon addition
of BP100. Nevertheless, no acquisition of conformation was detected in
the presence of these membranes by CD and NMR (Section 4.1).
4.5. Mechanism of action of BP100
In spite of the wealth of literature on AMP-membrane interaction
attempting to understand the mechanism of action of AMPs, a relatively
1997M.C. Manzini et al. / Biochimica et Biophysica Acta 1838 (2014) 1985–1999small number of studies points to the fact that this mechanism depends
on conditions such as peptide:lipid ratio, as well as membrane lipid
composition. The effects of these conditions on the mode of peptide
binding, activity, and lipid organization have been reported both in
experimental studies [e.g., refs. 11–13,23,86,87] andmolecular dynamics
calculations [88–93] of AMP-membrane interaction.
The present results, as well as the above discussion, are consistent
with the dependence of the mechanism of action of BP100 on peptide:
lipid ratio and on the proportion of PG in the membrane. CD and NMR
spectra provided evidence for α-helical conformation of membrane-
bound BP100. Furthermore, OCD and solid state 15 N NMR data [34], as
well as analysis by the Eisenberg formalism [56], indicated that BP100
is located on the membrane surface, with the helix axis parallel to
the surface. In addition, the analysis of peptide location according to
Eisenberg [56], indicated that BP100 is a surface-seeking peptide.
Moreover, BP100 is too short to span the bilayer thickness, especially
in the α-helical conformation. These aspects have to be taken into
consideration when discussing the possible mechanism(s) by which
the peptide affects membrane permeability.
Scheme 2 depicts the series of events proposed to occur under the
different conditions examined in the present study. At low peptide:
lipid ratios and low PG content the data do not provide evidence for
either peptide and/or lipid aggregation. Moreover, the leakage dataScheme 2. Proposed events occurring at low (high) BP100/lipid ratios and low (high) PG
contents. In the former (latter) case gradual (instantaneous) release of membrane inner
contents would be observed.are indicative of a gradual loss of the contents of the vesicles inner
aqueous compartment. This process could be due to peptide-promoted
perturbation of the bilayer acyl chain organization caused by electrostatic
interaction between the lipid and one or a few peptidemonomers. It has
been extensively shown that binding of small monomericmoleculesme-
diated by different types of forces can affect acyl chain packing and,
therefore, inﬂuence bilayer permeability. Different studies report either
a decrease or an increase in acyl chain packing upon binding of positively
charged peptides [94–97]. Moreover, other events may take place at low
peptide:lipid ratios and low PG content, such as lipid clustering [18–20,
98,99] whichwould promote formation of membrane defects at the bor-
der between peptide-bound and peptide-free clusters, and membrane
thinning [100]. These phenomena could occur independently or concom-
itantly, leading to a gradual release of membrane inner contents. While
the gradual release of inner contents is a consequence of membrane
perturbation by a small number of peptide molecules (monomers or
small aggregates), the essentially instantaneous loss of the inner con-
tents, under conditions of high peptide:lipid ratio and high PG, would
result from membrane disruption, the ﬁnal step of a sequence of
events – peptide-promoted lipid clustering, which in turn will pro-
mote peptide aggregation on the membrane surface, giving rise to
peptide-lipid patches that eventually would leave the membrane in
a carpet-like mechanism.Acknowledgements
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